Chart calendar Perspective Therapeutics, Inc.

c00c9d7ff98dfb8b391702b9d.OAlyatLOE4kIPbyXGvu1kx4wqgfAI_udVoAAXc8FSY8.D1hBJLivIN9ibsWvfLrq1Fxk4G6ZRbTUP-loHr1iCs5Zaj4HsLx8_mtF5Q~0173067d71c8fa0fdaf56adefd67c254

Upcoming events on Perspective Therapeutics, Inc.

11/08/2026

Earnings release - Q2 2026

Past events on Perspective Therapeutics, Inc.

27/05/2026

Annual General Meeting

18:00
12/05/2026

Earnings release - Q1 2026

04/05/2026

Présentation aux Actionnaires / Analystes

16:30
17/03/2026

Earnings release - Annual 2025

11/11/2025

Earnings release - Q3 2025

20/10/2025

Information meeting

16:30
13/08/2025

Earnings release - Q2 2025

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
1,43
8,46
-83.04%
1,45
1,46
-0.34%
0,88
1,07
-17.46%

0,42


0,49


13,5

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-64,5
-62,5
-3.18%
-110
-102
-8.35%

-127


-144


-153

EBIT
Million USD
Released
Forecast
Spread
-40,9
-43,4
5.6%
-66,8
-67,1
0.48%
-114
-103
-9.76%

-125


-145


-144

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-40,1
-43,0
6.64%
-80,4
-58,1
-38.42%
-104
-95,1
-9.84%

-120


-137


-132

Net income
Million USD
Released
Forecast
Spread
-46,5
-37,7
-23.33%
-79,3
-58,0
-36.62%
-103
-94,1
-9.57%

-120


-138


-137

EPS
USD
Released
Forecast
Spread
-1,70
-1,40
-21.43%
-1,23
-0,66
-87.27%
-1,40
-1,25
-11.82%

-1,10


-1,13


-1,07

Announcement Date28/03/2426/03/2516/03/26-

Quarterly results

Fiscal PeriodMarch 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,37
0,24
55.1%
0,23
0,28
-15.61%
0,34
0,14
137.62%
0,29
0,17
70.22%
0,21
0,21
1.04%
0,04
0,24
-81.86%
0,08
0,14
-44.6%

0,09


0,09


0,10


0,06


0,02


0,02


0,02

EBITDA
Million USD
Released
Forecast
Spread
-18,0
-14,5
-24.32%
-20,2
-17,6
-14.42%
-21,1
-19,5
-7.96%
-23,3
-19,8
-17.54%
-27,1
-21,7
-24.85%
-38,8
-25,5
-52.26%
-27,2
-39,7
31.6%

-29,2


-32,9


-37,6













EBIT
Million USD
Released
Forecast
Spread
-18,6
-16,5
-12.86%
-20,9
-21,2
1.47%
-21,8
-23,0
5.05%
-24,0
-24,0
-0.28%
-27,9
-26,0
-7.32%
-39,8
-29,7
-33.98%
-28,3
-33,9
16.5%

-30,5


-32,4


-34,3


-32,8


-34,0


-35,1


-36,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-15,1
-14,5
-4.09%
-41,3
-18,6
-122.37%
-18,2
-22,4
18.96%
-22,0
-22,5
2.33%
-26,0
-24,6
-5.7%
-38,3
-29,0
-31.92%
-26,2
-32,0
18.19%

-29,1


-31,1


-32,9


-31,5


-32,4


-33,5


-34,2

Net income
Million USD
Released
Forecast
Spread
-15,1
-14,6
-3.88%
-40,2
-18,5
-116.65%
-18,2
-22,4
18.96%
-21,5
-22,1
2.64%
-26,0
-24,4
-6.41%
-37,5
-28,3
-32.38%
-26,2
-32,2
18.77%

-29,0


-31,1


-33,4


-31,4


-32,6


-33,8


-34,8

EPS
USD
Released
Forecast
Spread
-0,21
-0,19
-9.65%
-0,61
-0,24
-152.55%
-0,25
-0,31
18.34%
-0,29
-0,30
2.08%
-0,35
-0,32
-7.88%
-0,51
-0,36
-40.94%
-0,25
-0,30
17.03%

-0,26


-0,27


-0,29


-0,30


-0,31


-0,30


-0,30

Announcement Date12/11/2426/03/2512/05/2513/08/2510/11/2516/03/2611/05/26-------
Today

Earnings release - Q2 2026

Today

Earnings presentation

00:30
05/08/2026

Earnings release - Q2 2026

05/08/2026

Earnings presentation

16:00
05/08/2026

Earnings presentation

17:00
05/08/2026

Earnings release - Q2 2026

05/08/2026

Earnings release - Q2 2026

05/08/2026

Earnings presentation

16:30
05/08/2026

Earnings release - Q2 2026

05/08/2026

Earnings presentation

00:30

Past sector events for Perspective Therapeutics, Inc.

31/07/2026

Annual General Meeting

14:00
31/07/2026

Earnings presentation

00:30
31/07/2026

Earnings release - Q2 2026

31/07/2026

Extraordinary General Meeting

10:30
30/07/2026

Earnings release - Q2 2026

30/07/2026

Earnings presentation

16:00
30/07/2026

Earnings release - Q2 2026

30/07/2026

Earnings presentation

12:00
30/07/2026

Earnings presentation

07:30
29/07/2026

Earnings release - Q2 2026

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CATX Stock
  4. Calendar Perspective Therapeutics, Inc.